Related Experiment Video
Updated: Feb 16, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Development of thyroid dysfunction is associated with clinical response to PD-1 blockade treatment in patients with
Hye In Kim1, Mijin Kim2, Se-Hoon Lee3
1Division of Endocrinology & Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Abstract:
Purpose: Drugs that blockade interaction between programmed cell-death protein 1 (PD-1) and its ligand (PD-L1) are promising. Immune-related adverse events (irAEs) might be associated with favorable clinical outcomes, and thyroid dysfunction is one of the most common irAE. We evaluated the association of thyroid dysfunction during PD-1 blockade with the treatment efficacy in patients with non-small cell lung cancer (NSCLC). Experimental Design: A total 58 patients with stage IV NSCLC treated with PD-1 blockade were enrolled. Patients were categorized into thyroid dysfunction and euthyroid groups. Overall survival (OS) and progression-free survival (PFS) of the two groups were compared. Patients, tumor, and medication factors were adjusted using Cox proportional hazard modeling. Objective response rate (RR) and durable control rate were assessed according to the severity of thyroid dysfunction. Results: OS [median 118.0 (73.0-267.0) vs. 71.0 (28.0-160.0) days, log-rank P = 0.025] and PFS [118.0 (73.0-267.0) vs. 61.0 (28.0-130.0), log-rank P = 0.014] were longer in the thyroid dysfunction group. After adjustment, thyroid dysfunction was an independent predictive factor for favorable outcome [adjusted HR = 0.11 (95% CI) 0.01-0.92 for overall death; 0.38 (0.17-0.85) for disease progression]. The severity of thyroid dysfunction was associated with durable control rate (P for trend = 0.008). Conclusions: Thyroid dysfunction during PD-1 blockade is associated with treatment response and could provide supplementary information for immune monitoring in patients with advanced NSCLC.
Insights
Thyroid dysfunction during programmed cell-death protein 1 (PD-1) blockade therapy is linked to better treatment outcomes in non-small cell lung cancer. This immune-related adverse event may serve as a predictive marker for improved survival and response rates.
Area of Science:
- Oncology
- Immunotherapy
- Endocrinology
Background:
- Programmed cell-death protein 1 (PD-1) and its ligand (PD-L1) inhibitors are effective cancer treatments.
- Immune-related adverse events (irAEs) can correlate with positive clinical outcomes.
- Thyroid dysfunction is a common irAE observed during PD-1 blockade therapy.
Purpose of the Study:
- To investigate the association between thyroid dysfunction and treatment efficacy in non-small cell lung cancer (NSCLC) patients receiving PD-1 blockade.
- To determine if thyroid dysfunction serves as a predictive factor for overall survival (OS) and progression-free survival (PFS).
Main Methods:
- Retrospective analysis of 58 stage IV NSCLC patients treated with PD-1 blockade.
- Categorization of patients into thyroid dysfunction and euthyroid groups.
- Comparison of OS and PFS between groups, with adjustments for patient, tumor, and medication factors using Cox proportional hazard modeling.
Main Results:
- Patients with thyroid dysfunction exhibited significantly longer OS (median 118.0 vs. 71.0 days) and PFS (median 118.0 vs. 61.0 days).
- Thyroid dysfunction was identified as an independent predictive factor for favorable outcomes (adjusted HR for death: 0.11; for progression: 0.38).
- The severity of thyroid dysfunction correlated with a higher durable control rate (P for trend = 0.008).
Conclusions:
- Thyroid dysfunction occurring during PD-1 blockade therapy is associated with enhanced treatment response in advanced NSCLC.
- Monitoring thyroid function may offer valuable insights for immune monitoring and predicting treatment success in these patients.
More Related Videos
Related Concept Videos
Neuromuscular Junction And Blockade
Treatment Resistant Cancers
Piaget's Stage 1 of Cognitive Development
Exploration...
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
The Thyroid Gland
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Lung Capacity

